Stock Events

Stock Events

Grifols SA 

$5.75
1102
-$0.03-0.52% Monday 20:00

Statistics

Day High
5.78
Day Low
5.78
52W High
7.14
52W Low
5.06
Volume
1,000
Avg. Volume
50
Mkt Cap
3.91B
P/E Ratio
14.57
Dividend Yield
1.64%
Dividend
0.09

Upcoming

Dividends

1.64%Dividend Yield
Jul 26
$0.05
Aug 25
$0.09
Jun 21
$0.22
Nov 20
$0.09
Dec 19
$0.11
10Y Growth
-12.12%
5Y Growth
-31.69%
3Y Growth
N/A
1Y Growth
-46.39%

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.15
0.2
0.24
0.29
Expected EPS
0.29055445107
Actual EPS
N/A

Financials

5.38%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.68BRevenue
466.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GIKLY. It's not an investment recommendation.
Repsol
169
REP.MC
Banco Santander.
152
SAN.MC
Enagas SA
150
ENG.MC
Telefonica
148
TEF.MC

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Carlisle Companies
CSL
Mkt Cap14.16B
CSL Limited is a global biotech leader that develops and delivers innovative biotherapies and influenza vaccines, directly competing with Grifols' plasma-derived products.
Takeda Pharmaceutical
TAK
Mkt Cap57.58B
Takeda Pharmaceutical Company operates in similar therapeutic areas as Grifols, including plasma-derived therapies and vaccines, making them direct competitors.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. produces critical care, nutrition, renal, hospital, and surgical products, including plasma-based therapies that compete with Grifols' offerings.
Biogen
BIIB
Mkt Cap32.28B
Biogen Inc. focuses on neurology, autoimmune and hematologic disorders, areas where Grifols also operates, especially in treatments derived from plasma.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a broad-based pharmaceutical company that, among many areas, competes with Grifols in the development of vaccines and treatments for rare diseases.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the healthcare field, overlapping with Grifols in the production of blood-related products.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. focuses on pharmaceuticals including plasma-based therapies, directly competing with Grifols in the immunology and oncology therapeutic areas.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. competes with Grifols in the biotechnology space, focusing on innovative human therapeutics, including treatments for illnesses that Grifols also targets.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops and markets medicines in areas of unmet medical need, including liver diseases, where Grifols also operates.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk A/S is a global healthcare company with a leading position in diabetes care, but also competes with Grifols in the hemophilia market with their biopharmaceuticals.

About

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Show more...
CEO
Jose Ignacio Abia Buenache
Employees
25247
Country
Spain
ISIN
US3984382008
WKN
000A1C3HH

Listings

F
DE
OZTA.F
MX
MX
GRFPN.MX
STU
DE
OZTA.STU
MI
IT
1GRF.MI

0 Comments

Share your thoughts

FAQ

What is Grifols SA stock price today?▼
The current price of GIKLY is $5.75 USD — it has decreased by -0.52% in the past 24 hours. Watch Grifols SA stock price performance more closely on the chart.
What is Grifols SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Grifols SA stocks are traded under the ticker GIKLY.
Is Grifols SA stock price growing?▼
GIKLY stock has risen by +0% compared to the previous week, the month change is a +12.75% rise, over the last year Grifols SA has showed a -23.23% decrease.
What is Grifols SA market cap?▼
Today Grifols SA has the market capitalization of 3.91B
When is the next Grifols SA earnings date?▼
Grifols SA is going to release the next earnings report on November 10, 2026.
What is Grifols SA revenue for the last year?▼
Grifols SA revenue for the last year amounts to 8.68B USD.
What is Grifols SA net income for the last year?▼
GIKLY net income for the last year is 466.9M USD.
Does Grifols SA pay dividends?▼
Yes, GIKLY dividends are paid semi-annual. The last dividend per share was 0.05 USD. As of today, Dividend Yield (FWD)% is 1.64%.
How many employees does Grifols SA have?▼
As of September 03, 2026, the company has 25,247 employees.
In which sector is Grifols SA located?▼
Grifols SA operates in the Health & Wellness sector.
When did Grifols SA complete a stock split?▼
The last stock split for Grifols SA was on January 04, 2016 with a ratio of 2:1.
Where is Grifols SA headquartered?▼
Grifols SA is headquartered in Barcelona, Spain.